Drug Type Biological products |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization iMetabolic Biopharma Corp.Startup |
Active Organization- |
Inactive Organization iMetabolic Biopharma Corp.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Nephropathies | Preclinical | US | iMetabolic Biopharma Corp.Startup | - |
Dyslipidemias | Preclinical | US | iMetabolic Biopharma Corp.Startup | - |